video thumbnail

Inflammatory Pathways - TLR and NLRP Pathways Modulation (Inflammation Part 2)

Duration: 41:11

Write A New Comment

2 Comments

...

easoren@*.com

Sep 09 2024, 7:57 pm

Wow! This explained a lot on the medicine and supplements I took and still taking, Thank you so much!

...

mobeen@*.com

Sep 09 2024, 4:38 pm

Welcome!

...

lhathawaymd@*.com

Sep 02 2024, 6:01 pm

Thank you, Drbeen for being blessed with the opportunity to share God's knowledge. All good is from God. You are a wonderful teacher.

...

mobeen@*.com

Sep 09 2024, 4:38 pm

Thank you.

Toll like receptor (TLR) and nucleotide-binding oligomerization domain (NOD), leucine-rich repeat (LRR)-containing proteins (NLR) proteins form sensors on our immune cells to detect pathogen associated molecular patterns (PAMPs) and damage associated molecular patterns (DAMPs). TLR receptors when activated prime the NLRP3 receptors. NLRP3 receptors when activated trigger the production of inflammasomes and subsequent cell death by pyroptosis. Both of these receptors and their pathways are important in creation and maintenance of inflammation. However, in subclinical/chronic inflammation these pathways can become potentially dysregulated. In this talk we will present an overview of these pathways, their interaction with each other and the possible ways to modulate these pathways.

Objectives:

1. Quick review of the key inflammatory pathways.

2. TLR pathway overview. 3. How TLR pathway primes NLRP

3.  Pathway.

4. NLRP3 pathway and its function for inflammasomal activity.

5. What are inflammasomes?

6. Studies demonstrating micronutrients that can modulate these pathways.

7. Role of hydroxychloroquine while modulating these pathways.

 

TLR Pathway Modulators Vitamin D, B12, A, Zinc, Copper, and Iron, Microbiome

Micronutrients and many important factors that affect the physiological functions of toll-like receptors | Bulletin of the National Research Centre | Full Text https://bnrc.springeropen.com/articles/10.1186/s42269-019-0165-z

The Association Between Gut Microbiota, Toll-Like Receptors, and Colorectal Cancer - PMC https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634190/

The TLR signaling pathway and downstream effector molecules. Depicted... | Download Scientific Diagram https://www.researchgate.net/figure/The-TLR-signaling-pathway-and-downstream-effector-molecules-Depicted-are-key-TLR_fig1_47567186

Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy https://www.nature.com/articles/s41392-020-00312-6

NLRP Pathway Modulators Important molecules involved in this pathway: Caspase-1, Caspase-11, cleavage of pro-IL-1beta and pro-IL-18 to IL-1beta and IL-18 (central to inflammation), Gasdermin D activation (creating membrane pores for pryoptosis (fiery death.)

We need to modulate NLRP pathway towards autophagic pathway and away from pyroptotoic pathway. Substances below help do it. However, don't use hydroxychloroquine with these to modulate NLRP, because HCQ will block autophagy and hence the effect of these supplements.

Note: in case you feel that the pyroptosis and autophagy both need to be stopped then HCQ can be used in combination with the products below.

Interventions:

Vitamin D, Omega-3, Curcumin, Resveratrol, Diet, and Exercise

The role of vitamin D3 in modulating the interplay between NLRP3 inflammasome and autophagy in NASH - PubMed https://pubmed.ncbi.nlm.nih.gov/37951152/

The role of vitamin D3 in modulating the interplay between NLRP3 inflammasome and autophagy in NASH - PubMed https://pubmed.ncbi.nlm.nih.gov/37951152/

Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance - PubMed https://pubmed.ncbi.nlm.nih.gov/25149823/

The Effects of Curcumin on Inflammasome: Latest Update - PMC https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866118/

Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy - PubMed https://pubmed.ncbi.nlm.nih.gov/25535911/

The Effect of Adherence to Mediterranean Diet on Disease Activity in Patients with Inflammatory Bowel Disease - PMC https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441165/

The anti-inflammatory effect of exercise | Journal of Applied Physiology https://journals.physiology.org/doi/full/10.1152/japplphysiol.00164.2004

Allopathic Medicine: No drugs at the moment that modulate NLRP. However, there are molecules in pre-clinical and clinical trials to modulate NLRP.

Allopathic Medicine: No drugs at the moment that modulate NLRP. However, there are molecules in pre-clinical and clinical trials to modulate NLRP.

1. Quick review of the key inflammatory pathways.

2. TLR pathway overview.

3. How TLR pathway primes NLRP3 pathway.

4. NLRP3 pathway and its function for inflammasomal activity.

5. What are inflammasomes?

6. Studies demonstrating micronutrients that can modulate these pathways.

7. Role of hydroxychloroquine while modulating these pathways.

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Faculty

In addition to the presenter, following authors may have helped with the content writing, review, or approval:

  • Dr. Mobeen Syed

CME, CE, CEU and Other Credit Types:

ACCME Accreditation Statement
The DrBeen Corp is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The DrBeen Corp designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure Information

In accordance with the disclosure policies of DrBeen Corp and the ACCME (Accreditation Council for Continuing Medical Education), we are committed to upholding principles of balance, independence, objectivity, and scientific rigor in all of our Continuing Medical Education (CME) and Continuing Education (CE) activities. These policies include the careful management and mitigation of any relevant financial relationships with organizations that are not eligible.
All members of the Activity Planning Committee and presenters have disclosed their relevant financial relationships. The DrBeen Corp CE Committee has thoroughly reviewed these disclosures and determined that these relationships are not deemed inappropriate in the context of their respective presentations. Additionally, they are found to be consistent with the educational objectives and the integrity of the activity.

Faculty Disclosures
Dr. Mobeen Syed Author declares no conflict of interest.

Please login to access this content.

Don't have an account?

Start Your Free trial

No credit card information needed.

Instructors

Dr. Mobeen Syed

Dr. Mobeen Syed

MD., MSc., MSc., BSc

Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.

Inflammation

Related Videos